Q3 2023 13F Holders as of 9/30/2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
129M
-
Number of holders
-
273
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
+2.89M
-
Total reported value, excl. options
-
$1.44B
-
Value change
-
+$29.2M
-
Put/Call ratio
-
0.32
-
Number of buys
-
103
-
Number of sells
-
-122
-
Price
-
$12.30
Significant Holders of NEOGENOMICS INC - Common Stock (NEO) as of Q3 2023
305 filings reported holding NEO - NEOGENOMICS INC - Common Stock as of Q3 2023.
NEOGENOMICS INC - Common Stock (NEO) has 273 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
of 129M outstanding shares and own 90.83% of the company stock.
Largest 10 shareholders include BlackRock Inc. (20.1M shares), VANGUARD GROUP INC (14.3M shares), BROWN ADVISORY INC (8.25M shares), JANUS HENDERSON GROUP PLC (7.17M shares), T. Rowe Price Investment Management, Inc. (5.53M shares), STATE STREET CORP (4.92M shares), Greenhouse Funds LLLP (3.98M shares), First Light Asset Management, LLC (3.03M shares), MACQUARIE GROUP LTD (3.02M shares), and DIMENSIONAL FUND ADVISORS LP (2.99M shares).
This table shows the top 273 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.